UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 100

Sortiert nach

Mechanisms and monitoring of bypassing agent therapy

Journal of thrombosis and haemostasis, 2012-08, Vol.10 (8), p.1478-1485

2012

Link zum Volltext

Verfügbarkeit prüfen

Proposal for standardized preanalytical and analytical conditions for measuring thrombin generation in hemophilia: communication from the SSC of the ISTH

Journal of thrombosis and haemostasis, 2017-08, Vol.15 (8), p.1704-1707

2017

Link zum Volltext

Verfügbarkeit prüfen

Hypersensibilité retardée aux héparines : diagnostic et prise en charge thérapeutique

Annales de dermatologie et de vénéréologie, 2012-05, Vol.139 (5), p.363-368

2012

Link zum Volltext

Verfügbarkeit prüfen

Individualized PK‐based prophylaxis in severe haemophilia

Haemophilia : the official journal of the World Federation of Hemophilia, 2018-03, Vol.24 (S2), p.3-17

2018

Link zum Volltext

Verfügbarkeit prüfen

Individual thrombin generation and spontaneous bleeding rate during personalized prophylaxis with Nuwiq® (human‐cl rhFVIII) in previously treated patients with severe haemophilia A

Haemophilia : the official journal of the World Federation of Hemophilia, 2018-07, Vol.24 (4), p.619-627

2018

Link zum Volltext

Verfügbarkeit prüfen

Personalized thromboprophylaxis using a risk score for the management of pregnancies with high risk of thrombosis: a prospective clinical study

Journal of thrombosis and haemostasis, 2017-05, Vol.15 (5), p.897-906

2017

Link zum Volltext

Verfügbarkeit prüfen

Intérêt d’une démarche de pharmacie clinique au sein des observatoires des traitements des filières de santé maladies rares : exemple de la filière MHEMO

Le Pharmacien Clinicien, 2024-06, Vol.59 (2), p.e161-e161

2024

Link zum Volltext

Verfügbarkeit prüfen

Thrombose hémostase et cancer : les mécanismes physiopathologiques en jeu

Oncologie (Paris, France), 2012-12, Vol.14 (12), p.638-643

Dargaud, Y.

2012

Link zum Volltext

Verfügbarkeit prüfen

Tests of global haemostasis and their applications in bleeding disorders

Haemophilia : the official journal of the World Federation of Hemophilia, 2010-07, Vol.16 (s5), p.85-92

2010

Link zum Volltext

Verfügbarkeit prüfen

Seventy-two total knee arthroplasties performed in patients with haemophilia using continuous infusion

Vox sanguinis, 2013-02, Vol.104 (2), p.135-143

2013

Link zum Volltext

Verfügbarkeit prüfen

Diagnosis and management challenges in patients with mild haemophilia A and discrepant FVIII measurements

Haemophilia : the official journal of the World Federation of Hemophilia, 2014-07, Vol.20 (4), p.550-558

2014

Link zum Volltext

Verfügbarkeit prüfen

Thrombin generation testing in haemophilia comprehensive care centres

Haemophilia : the official journal of the World Federation of Hemophilia, 2010-03, Vol.16 (2), p.223-230

2010

Link zum Volltext

Verfügbarkeit prüfen

Thrombose hémostase et cancer: les mécanismes physiopathologiques en jeu : Thrombose et cancer

Oncologie (Paris, France), 2012, Vol.14 (12), p.638-643

DARGAUD, Y

2012

Link zum Volltext

Verfügbarkeit prüfen

Standardisation of thrombin generation test - which reference plasma for TGT?: An international multicentre study

Thrombosis research, 2010-04, Vol.125 (4), p.353-356

2010

Link zum Volltext

Verfügbarkeit prüfen

Genotyping might help therapeutic decision-making in patients with von Willebrand disease type 2 B

Haemophilia : the official journal of the World Federation of Hemophilia, 2016-09, Vol.22 (5), p.e439-e443

2016

Link zum Volltext

Verfügbarkeit prüfen

Thrombin generation in patients with factor XI deficiency and clinical bleeding risk

Haemophilia : the official journal of the World Federation of Hemophilia, 2010-09, Vol.16 (5), p.771-777

2010

Link zum Volltext

Verfügbarkeit prüfen

Combined life-threatening thromboses and hemorrhages in a patient with afibrinogenemia and antithrombin deficiency

Thrombosis journal, 2018-04, Vol.16 (1), p.6-6, Article 6

2018

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of the overall haemostatic effect of recombinant factor VIIa by measuring thrombin generation and stability of fibrin clots

Haemophilia : the official journal of the World Federation of Hemophilia, 2011-11, Vol.17 (6), p.957-961

2011

Link zum Volltext

Verfügbarkeit prüfen

Hypofibrinolytic state and high thrombin generation may play a major role in SARS‐COV2 associated thrombosis

Journal of thrombosis and haemostasis, 2020-09, Vol.18 (9), p.2215-2219

2020

Link zum Volltext

Verfügbarkeit prüfen

Reversal of the inhibitory effect of Fondaparinux on Thrombin generation by rFVIIa, aCCP and PCC

Thrombosis research, 2009-03, Vol.123 (5), p.796-798

2009

Link zum Volltext

Verfügbarkeit prüfen

New advances in the therapeutic and laboratory management of patients with haemophilia and inhibitors

Haemophilia : the official journal of the World Federation of Hemophilia, 2008-07, Vol.14 (s4), p.20-27

2008

Link zum Volltext

Verfügbarkeit prüfen

Bleeding risk in warfarinized patients with a therapeutic international normalized ratio: the effect of low factor IX levels

Journal of thrombosis and haemostasis, 2013-06, Vol.11 (6), p.1043-1052

2013

Link zum Volltext

Verfügbarkeit prüfen

Global haemostasis and point of care testing

Haemophilia : the official journal of the World Federation of Hemophilia, 2012-07, Vol.18 (s4), p.81-88

2012

Link zum Volltext

Verfügbarkeit prüfen

Thrombin generation assay using factor IXa as a trigger to quantify accurately factor VIII levels in haemophilia A

Journal of thrombosis and haemostasis, 2011-08, Vol.9 (8), p.1549-1555

2011

Link zum Volltext

Verfügbarkeit prüfen

In vivo efficacy of human recombinant factor IX produced by the human hepatoma cell line HuH-7

Haemophilia : the official journal of the World Federation of Hemophilia, 2015-07, Vol.21 (4), p.e317-e321

2015

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 100

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(87)
Mit Volltextzugriff
(90)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Mechanisms and monitoring of bypassing agent therapy

Proposal for standardized preanalytical and analytical conditions for measuring thrombin generation in hemophilia: communication from the SSC of the ISTH

Hypersensibilité retardée aux héparines : diagnostic et prise en charge thérapeutique

Individualized PK‐based prophylaxis in severe haemophilia

Individual thrombin generation and spontaneous bleeding rate during personalized prophylaxis with Nuwiq® (human‐cl rhFVIII) in previously treated patients with severe haemophilia A

Personalized thromboprophylaxis using a risk score for the management of pregnancies with high risk of thrombosis: a prospective clinical study

Intérêt d’une démarche de pharmacie clinique au sein des observatoires des traitements des filières de santé maladies rares : exemple de la filière MHEMO

Thrombose hémostase et cancer : les mécanismes physiopathologiques en jeu

Tests of global haemostasis and their applications in bleeding disorders

Seventy-two total knee arthroplasties performed in patients with haemophilia using continuous infusion

Diagnosis and management challenges in patients with mild haemophilia A and discrepant FVIII measurements

Thrombin generation testing in haemophilia comprehensive care centres

Thrombose hémostase et cancer: les mécanismes physiopathologiques en jeu : Thrombose et cancer

Standardisation of thrombin generation test - which reference plasma for TGT?: An international multicentre study

Genotyping might help therapeutic decision-making in patients with von Willebrand disease type 2 B

Thrombin generation in patients with factor XI deficiency and clinical bleeding risk

Combined life-threatening thromboses and hemorrhages in a patient with afibrinogenemia and antithrombin deficiency

Evaluation of the overall haemostatic effect of recombinant factor VIIa by measuring thrombin generation and stability of fibrin clots

Hypofibrinolytic state and high thrombin generation may play a major role in SARS‐COV2 associated thrombosis

Reversal of the inhibitory effect of Fondaparinux on Thrombin generation by rFVIIa, aCCP and PCC

New advances in the therapeutic and laboratory management of patients with haemophilia and inhibitors

Bleeding risk in warfarinized patients with a therapeutic international normalized ratio: the effect of low factor IX levels

Global haemostasis and point of care testing

Thrombin generation assay using factor IXa as a trigger to quantify accurately factor VIII levels in haemophilia A

In vivo efficacy of human recombinant factor IX produced by the human hepatoma cell line HuH-7

Suchergebnisse filtern